comparemela.com

Latest Breaking News On - Erin frances cobain - Page 1 : comparemela.com

Dr Cobain on the Importance of Molecular Testing in Metastatic Breast Cancer

Dr Cobain on the Importance of Molecular Testing in Metastatic Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesErin frances cobainBreast cancer clinical research teamRogel cancer centerUniversity of michiganInstitutional perspectives

Dr Cobain on Future Considerations For the Treatment of HR+/HER2– Breast Cancer

Erin Frances Cobain, MD, discusses key takeaways from an OncLive Institutional Perspectives in Cancer webinar on breast cancer.

United statesErin frances cobainUniversity of michiganRogel cancer centerBreast cancer clinical research teamOnclive institutional perspectives

Dr Cobain on Endocrine Therapy–Based Treatment Strategies in HR+/HER2– Breast Cancer

Erin Frances Cobain, MD, discusses optimal endocrine therapy–based treatment strategies in later-line settings for HR-positive/HER2-negative breast cancer.

United statesErin frances cobainUniversity of michiganRogel cancer centerBreast cancer clinical research teamUniversity of michiganOnclive tvBreast cancer

Ongoing Research Drives Further Questions in Early-Stage Breast Cancer Management

Erin Frances Cobain, MD, discusses unanswered questions regarding the use of ribociclib and immunotherapy in early-stage breast cancer.

Margaret gatti maysErin frances cobainMonika burnessBreast cancer clinical research teamAlliance for clinical trials in oncologyUniversity of michigan rogel cancer centerOnclive institutional perspectivesMichigan rogel cancer centerAnn arborClinical trialsEarly stage breast cancerTriple negative breast cancer

The Road Beyond Frontline CDK4/6 Inhibitors in HR+/HER2– Metastatic Breast Cancer Examines Combinations

Erin Frances Cobain, MD, highlights the current role of endocrine therapy and CDK4/6 inhibitors in HR-positive, HER2-negative metastatic breast cancer.

United statesSan antonioAnn arborErin frances cobainAmerican society of clinical oncology annual meetingUniversity of michigan rogel cancer centerUniversity of michiganBreast cancer clinical research teamOnclive institutional perspectivesMichigan rogel cancer centerSan antonio breast cancer symposiumAmerican societyClinical oncology annual

vimarsana © 2020. All Rights Reserved.